Systane® COMPLETE Lubricant Eye Drops
ALL-IN-ONE RELIEF for all types of irritated, dry eyes1
Be unstoppable with Systane® COMPLETE. This ALL-IN-ONE formula is clinically proven to relieve all types of Dry Eye1 so your eyes won't hold you back.
Key Benefits
- ALL-IN-ONE Dry Eye Relief for all types of irritated, tired, dry eyes1
- Clinically proven relief from Dry Eye symptoms for up to 8 hours1
- Easy to use multi-dose bottle
- For mild to moderate, self-treating, occasional sufferers*
Product Information & Usage
Product Information
- For all types of dry eye1 (Mixed, Aqueous & Lipid Deficient)
- Hydrates and protects the ocular surface for up to 8 hours1
- Works on all layers of the tear film2
- With nano-droplet technology
- Available size: 10ml multi-dose bottle
Product Usage
- May be used as needed throughout the day
- Place 1 or 2 drops in the affected eye(s) as needed and blink
- Can be used before wearing contact lenses and/or after removing contact lenses**
Systane® COMPLETE Lubricant Eye Drops FAQs
- How is Systane® COMPLETE different?
- Can you use Systane® COMPLETE lubricant eye drops with contact lenses?
- How long does Systane® COMPLETE last after opening?
Systane® COMPLETE is a preserved formulation suitable for occasional users, which contains a very small quantity of the preservative (POLYQUAD™ 0.001%). It is our advanced and complete eye drops to relieve symptoms of any type of Dry Eye.1,2
Ingredients & Safety
A sterile white emulsion containing propylene glycol, hydroxypropyl guar, mineral oil, dimyristoyl phosphatidylglycerol, polyoxyl 40 stearate, sorbitan tristearate, boric acid, sorbitol, edetate disodium, POLYQUAD™ (polyquaternium-1) 0.001% preservative, and purified water. May contain hydrochloric acid and/or sodium hydroxide to adjust pH.
*Based on internal assessment and patient segmentation.
**Please refer to relevant instructions for use.
References:
1. Silverstein S, Yeu E, Tauber J, et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:3167-3177.
2. Ketelson H, Rangarjan R. Pre-clinical evaluation of a novel phospholipid nanoemulsion based lubricant eye drops. Poster presented at ARVO 2017, Baltimore, MD.
Consult your healthcare or eye care professional for use, precautions, warnings and contraindications.